https://www.bloomberg.com/news/articles/2022-03-11/-buy-now-pay-later-lender-affirm-delays-asset-backed-bond-sale
UniQure Expands Gene Therapies Pipeline For Neurological Disorders With Corlieve Acquisition
UniQure N.V. (NASDAQ:QURE) has agreed to acquire Corlieve Therapeutics and its lead program for temporal lobe epilepsy (TLE), the most common…